NanoVibronix, Inc. (NASDAQ: NAOV) (the "Company"), a medical technology company specializing in non-invasive therapeutic devices, today announced that an independent health service study of its ...

Report shows hospitals outperform pre-pandemic levels, boosting patient safety, care experience and workforce resilience.

The study highlights UroShield’s effectiveness in preventing catheter-associated urinary tract infections (CAUTIs ... enhancing patient care by reducing CAUTI incidence and catheter blockages ...

Urinary tract infections (UTIs) are the most common infectious problem among older adults both in the community and institutional settings. With the expected increase in this population ...

Urinary tract infection (UTI) is the most common serious bacterial infection in childhood. Prompt diagnosis and treatment are required for the optimal clinical outcome and the prevention of long ...

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on ...

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on ...

Viral infection is the invasion of the body by a small agent known as a virus. Viruses replicate inside host cells and can produce toxins that cause disease. The immune system helps to destroy ...

1. Current NAV: The Current Net Asset Value of the UTI Balanced Advantage Fund - Regular Plan as of Mar 12, 2025 is Rs 11.67 for Growth option of its Regular plan. 2. Returns: Its trailing returns ...